Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
InoCard
company
About
InoCard is a biotechnology company and develops AAV-based gene therapy approach for the long-term treatment of congestive heart failure.
Details
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2013
- Operating Status
- Active
InoCard is a biotechnology company and develops AAV-based gene therapy approach for the long-term treatment of congestive heart failure, targeting the calcium-binding protein S100A1.
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
